Dual targeting of ferroptosis and immune evasion: STAT3 inhibition as a one-two punch for breast cancer immunotherapy
Jianbo Zhou, Cailu Song, Zhi Tian, Hailin Tang, Fu Peng · 2026
Read Dual targeting of ferroptosis and immune evasion: STAT3 inhibition as a one-two punch for breast cancer immunotherapy by Jianbo Zhou, Cailu Song, Zhi Tian, Hailin Tang, Fu Peng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13508832.txt.
Description
Jianbo Zhou and co-authors comment on a breast cancer study that targets a growth switch called STAT3, in a 2026 commentary. The switch is switched on in many cancers and drives both growth and escape from the immune system. It also helps cancer cells resist a form of iron-driven cell death. A recent study showed a natural compound blocking the switch, which triggered that cell death and boosted response to immune therapy.
The commentators praise the study logic and its wide evidence, but they flag limits. The compound screening covered only a small panel of cell lines, centred on the most aggressive breast cancer subtype. Such limits, they argue, restrict how far the results can travel toward the clinic and to other patients. They set out the rationale for switch blockers in breast cancer immune therapy, and the questions that still need answers before use.
Catalog record
| CREATOR | Jianbo Zhou, Cailu Song, Zhi Tian, Hailin Tang, Fu Peng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |